Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Joseph

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Osteoarthritis and Cartilage Open|January 15, 2026
Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 studyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
The American Journal of Sports Medicine|June 27, 2023
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled StudyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
The Journal of the Association of Physicians of India|February 2, 2025
A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal OsteoporosisThomas Paul, Bhavuk Garg, Nitin Kapoor, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Osteoarthritis and Cartilage Open|January 15, 2026
Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 studyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
The American Journal of Sports Medicine|June 27, 2023
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled StudyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
The Journal of the Association of Physicians of India|February 2, 2025
A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal OsteoporosisThomas Paul, Bhavuk Garg, Nitin Kapoor, et al.
Pageof 6